SCHEMBL6133824

SCHEMBL6133824

CC(C)n1nc(-c2sc(N)nc2-c2cccc(F)c2)ccc1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 2/20 0.39
TGFBR1 P36897 2/20 0.39
ALDH1A1 P00352 3/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
ADORA2A P29274 2/20 0.37
ADORA1 P30542 2/20 0.37
CYP1A2 P05177 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
KDM5B Q9UGL1 1/20 0.36
BACE1 P56817 1/20 0.36
USP2 O75604 1/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
ALPL P05186 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6134397 0.87 TGFBR1 (0.53) MAPTMEN1KMT2AKDM4ETGFBR1
SCHEMBL6134033 0.87 TGFBR1 (0.48) MAPTKDM4ETGFBR1ALDH1A1LMNA
SCHEMBL6134226 0.87 ALDH1A1 (0.51) MAPTMEN1KMT2AKDM4ETGFBR1
SCHEMBL6133334 0.86 HPGDS (0.38) MAPK1KDM5BALPLALPIBRAF
Bromide SCHEMBL6133333 0.85 ALDH1A1 (0.50) MAPTMEN1KMT2AKDM4ETGFBR1
SCHEMBL6134138 0.82 RORC (0.40) KDM4EALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL6133426 0.81 TGFBR1 (0.45) MAPTKDM4ETGFBR1ALDH1A1ADORA2A
SCHEMBL28658385 0.81 ADORA2A (0.47) MAPTMEN1KMT2AKDM4ETGFBR1
SCHEMBL6133357 0.80 TRPM8 (0.45) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL6134062 0.79 MAP4K4 (0.41) KMT2AALPLALPIBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed
EP-1441732-A2 THIAZOLE DERIVATIVE AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-04 EP disclosed
WO-2003039451-A2 THIAZOLE PYRIDAZINONES AS ADENOSINE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR MAPT 3008/4885MEN1 2508/4885KMT2A 2724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.